Title:
ANTI-5T4 ANTIBODIES AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/155925
Kind Code:
A1
Abstract:
This disclosure provides anti-5T4 antibodies, variants thereof and humanized versions. The newly disclosed antibodies exhibited high affinity to the 5T4 protein and can be used to treat cancers.
Inventors:
LIU FANG (CN)
GONG WENCI (CN)
CAI ZHIJIAN (CN)
YANG LIU (CN)
GAO SHAN (CN)
JIANG WENQING (CN)
FANG LEI (CN)
GONG WENCI (CN)
CAI ZHIJIAN (CN)
YANG LIU (CN)
GAO SHAN (CN)
JIANG WENQING (CN)
FANG LEI (CN)
Application Number:
PCT/CN2023/077493
Publication Date:
August 24, 2023
Filing Date:
February 21, 2023
Export Citation:
Assignee:
CONCEPT TO MEDICINE BIOTECH CO LTD (CN)
International Classes:
C07K16/32; A61K39/395; A61P35/00; C07K16/30; C07K16/46; C07K19/00; C12N15/02
Domestic Patent References:
| WO2014137931A1 | 2014-09-12 |
Foreign References:
| US20060088522A1 | 2006-04-27 | |||
| US20140081005A1 | 2014-03-20 | |||
| US20140308302A1 | 2014-10-16 | |||
| US20190194346A1 | 2019-06-27 | |||
| US20190374651A1 | 2019-12-12 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: GUIDE RNA AND USES THEREOF
Next Patent: TUMOR ANTIGEN-DEPENDENT CD40 AGONIST ANTIBODIES
Next Patent: TUMOR ANTIGEN-DEPENDENT CD40 AGONIST ANTIBODIES